Skip to main content

CVE detail

CVE-2020-28388

A vulnerability has been identified in APOGEE PXC Compact (BACnet) (All versions < V3.5.5), APOGEE PXC Compact (P2 Ethernet) (All versions < V2.8.20), APOGEE PXC Modular (BACnet) (All versions < V3.5.5), APOGEE PXC Modular (P2 Ethernet) (All versions < V2.8.20), Nucleus NET (All versions < V5.2), Nucleus ReadyStart V3 (All versions < V2012.12), Nucleus Source Code (All versions), PLUSCONTROL 1st Gen (All versions), TALON TC Compact (BACnet) (All versions < V3.5.5), TALON TC Modular (BACnet) (All versions < V3.5.5). Initial Sequence Numbers (ISNs) for TCP connections are derived from an insufficiently random source. As a result, the ISN of current and future TCP connections could be predictable. An attacker could hijack existing sessions or spoof future ones.

CVSS 6.5 · MediumBuzz score 16.0

Buzz score

Why this CVE is surfacing

Buzz score total 16.0

This all-time snapshot uses the same composite formula as Trending across a 30-year evidence window, rather than a current rolling window.

Buzz score components · mention 11.0 · diversity 5.0 · KEV 0.0 · OTX 0.0 · PoC 0.0
Mention score
11.0
2 evidence mentions in the snapshot
Diversity score
5.0
1 sources across 1 categories
KEV score
0.0
No KEV entry observed
OTX score
0.0
0 OTX pulses
PoC score
0.0
0 repos · best confidence N/A
Best PoC traction
0
Maximum stars on a matched PoC repo

Why it matters now

Mention timeline

Total mentions
0
within the 30d window
Peak daily
0
highest bucket

Evidence

Source links by recency

Newest mentions first
2 source links · newest first

Exploit code

Public exploit repository references

Public PoC repositories are third-party, potentially unsafe artifacts. Treat their code as untrusted and use it only on authorized systems in an isolated, least-privilege environment. cvebuzz does not execute the code or verify that an exploit works.

0 repository references · best confidence N/A · max 0 stars
No public PoC repositories have been matched yet.

Related records

Similar CVEs

6 related CVEs with shared weakness or product evidence